BioMarin Pharmaceutical Inc. buy StockNews.com
Start price
22.02.25
/
50%
€65.26
Target price
22.02.26
-
Performance (%)
-17.99%
End price
23.02.26
€53.52
Summary
This prediction ended on 23.02.26 with a price of €53.52. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.99%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 5.547% | 5.547% | 16.908% |
| iShares Core DAX® | 0.437% | 5.640% | 7.806% |
| iShares Nasdaq 100 | 1.057% | 0.282% | 27.239% |
| iShares Nikkei 225® | 1.769% | 0.406% | 49.266% |
| iShares S&P 500 | 0.368% | 1.920% | 22.336% |
Comments by StockNews_com for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€66.60
10.03.25
10.03.25
-
10.03.26
10.03.26
-21.50%
11.03.26
11.03.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€67.70
02.03.25
02.03.25
-
02.03.26
02.03.26
-25.47%
03.03.26
03.03.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€88.08
29.04.23
29.04.23
-
29.04.24
29.04.24
-13.03%
30.04.24
30.04.24